Polymerase chain reaction (PCR) test detects more oesophageal cancers:
This article was originally published in Clinica
Testing for the biochemical marker carcinoembryonic antigen (CEA) could increase the detection of cancer spread from the oesophagus, US researchers have said. Using reverse transcriptase PCR, researchers at the University of Pittsburgh analysed 123 lymph nodes from 30 patients with oesophageal cancer. Of the 73 nodes that were negative on histology, 33 were found to have CEA mRNA and would therefore be classed as node-positive tumours. Use of the test increased the number of node-positive tumours from 41% to 70%.
You may also be interested in...
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.